Martin Shkreli
Martin Shkreli's Turing Pharmaceuticals is reneging on its pledge to cut the $750-per-pill price for Daraprim, a medication that has been marketed for 62 years. Instead, the biotech company is reducing what it charges hospitals, by up to 50 percent, for this parasitic infection treatment. Imprimis Pharmaceuticals, a pharmacy that compounds prescription drugs for individual patients, started selling a custom-made version of Pyrimethamine, the chemical name for Daraprim, for 99 cents per capsule. Impris reports orders are pouring in from doctors.
Sources: AP via Washington Post